Repeated Relapse-Retreatment Cycles After Omalizumab Withdrawal in Chronic Spontaneous Urticaria: A Real-World Study. (PubMed, J Clin Med) - Oct 17, 2026 - "Routinely available baseline clinical and laboratory parameters did not reliably distinguish patients who developed this relapse-retreatment pattern. These findings highlight the difficulty of predicting repeated retreatment requirements from conventional baseline assessments and support further prospective investigation of individualized withdrawal and step-down strategies in patients who develop recurrent relapse-retreatment cycles."
Journal • Real-world evidence • Cardiovascular • Chronic Spontaneous Urticaria • Dermatology • Endocrine Disorders • Immunology • Urticaria • CRP
|